Novartis | Capital De Empréstimo



Loan Capital Alterar Data
AbbVie USD 60.34B 1.83B 2024-12
Amgen USD 54.01B 2.54B 2025-03
AstraZeneca USD 27.89B 154M 2025-03
Bausch Health Companies USD 21.23B 2.29B 2025-03
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Canopy Growth CAD 467.93M 34.44M 2024-12
Corcept Therapeutics USD 0 0 2025-03
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 34.5B 5.97B 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Indivior 311M 4M 2025-03
J&J USD 38.36B 7.7B 2025-03
Merck USD 33.48B 978M 2025-03
Novartis USD 22.93B 2.41B 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pacira USD 381.29M 2.26M 2025-03
Perrigo USD 3.59B 9.6M 2025-03
Pfizer USD 57.64B 234M 2025-03
Prestige Brands USD 1.01B 16.93M 2025-03
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.41B 1.62B 2025-03
Sanofi 11.79B 712M 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
Zoetis USD 5.23B 7M 2025-03



Novartis Capital De Empréstimo - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.